山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (6): 138-141.doi: 10.6040/j.issn.1673-3770.0.2020.487
张小艳,郝晓凤,谢立科
ZHANG Xiaoyan, HAO Xiaofeng,XIE Like
摘要: 脉络膜骨瘤是一种少见的由成熟松质骨逐渐替代脉络膜组织形成的脉络膜良性肿瘤。肿瘤的生长、脱钙、视网膜色素上皮的改变、脉络膜新生血管的形成、视网膜下液的产生等均可导致视力下降。近年来随着眼底影像学技术不断更新,相干光断层扫描(OCT)在脉络膜骨瘤的应用中,发现了很多新的特征性的表现。本文针对脉络膜骨瘤OCT特征的最新研究进展进行总结和分析,以期为正确解读脉络膜骨瘤患者的OCT结果提供临床参考。
中图分类号:
[1] Gass JD. New observations concerning choroidal osteomas[J]. Int Ophthalmol, 1979, 1(2): 71-84. doi:10.1007/bf00154194. [2] Gass JD, Guerry RK, Jack RL, et al. Choroidal osteoma[J]. Arch Ophthalmol, 1978, 96(3): 428-435. doi:10.1001/archopht.1978.03910050204002. [3] Mazloumi M, Dalvin LA, Ancona-Lezama D, et al. Photodynamic therapy for extrafoveolar choroidal osteoma[J]. Retina, 2020, 40(5): 966-971. doi:10.1097/iae.0000000000002534. [4] Shields CL, Sun H, Demirci H, et al. Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma[J]. Arch Ophthalmol, 2005, 123(12):1658-1666. doi:10.1001/archopht.123.12.1658. [5] Xuan Y, Zhang Y, Wang M, et al. Multimodal fundus imaging of outer retinal tubulations in choroidal osteoma patients[J]. Retina, 2018, 38(1): 49-59. doi:10.1097/iae.0000000000001498. [6] Aronow ME, Crowell EL, Reddy AK. Bilateral choroidal osteoma of childhood[J]. JAMA Ophthalmol, 2019, 137(10): e185998. doi:10.1001/jamaophthalmol.2018.5998. [7] Aksoy Y, Çakir Y, Sevinçli S, et al. Choroidal osteoma in a preterm infant[J]. Indian J Ophthalmol, 2018, 66(4): 583-585. doi:10.4103/ijo.IJO_914_17. [8] Chen J, Lee L, Gass JD. Choroidal osteoma: evidence of progression and decalcification over 20 years[J]. Clin Exp Optom, 2006, 89(2): 90-94. doi:10.1111/j.1444-0938.2006.00012.x. [9] Shields CL, Sun H, Demirci H, et al. Factors predictive of tumor growth, tumor decalcification, choroidal?neovascularization, and visual outcome in 74 eyes with choroidal osteoma[J]. Arch Ophthalmol, 2005, 123(12): 1658-1666. doi:10.1001/archopht.123.12.1658. [10] Ugo I, Giuseppe C, Maurizio BP, et al. Diagnostic and therapeutic challenges edited by H. Richard McDonald[J]. Retina, 2016, 36(2): 422-427. doi: 10.1097/IAE.0000000000000591. [11] Papastefanou VP, Pefkianaki M, Al Harby L, et al. Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma[J]. Eye(Lond), 2016, 30(6): 843-849. doi:10.1038/eye.2016.50. [12] Browning DJ. Choroidal osteoma: observations from a community setting[J]. Ophthalmology, 2003, 110(7): 1327-1334. doi:10.1016/S0161-6420(03)00458-5. [13] Szelog JT, Bonini Filho MA, Lally DR, et al. Optical coherence tomography angiography for detecting choroidal neovascularization secondary to choroidal osteoma[J]. Ophthalmic Surg Lasers Imaging Retina, 2016, 47(1): 69-72. doi:10.3928/23258160-20151214-10. [14] Khan MA, DeCroos FC, Storey PP, et al. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma[J]. Retina, 2014, 34(9): 1750-1756. doi:10.1097/IAE.0000000000000187. [15] Ahmadieh H, Vafi N. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab(Avastin)[J]. Albrecht Von Graefes Arch Fur Klinische Und Exp Ophthalmol, 2007, 245(11): 1731-1733. doi:10.1007/s00417-007-0636-z. [16] Liu YQ, Berendsen AD, Jia SD, et al. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation[J]. J Clin Invest, 2012, 122(9): 3101-3113. doi:10.1172/JCI61209. [17] Zweifel SA, Engelbert M, Laud K, et al. Outer retinal tubulation: a novel optical coherence tomography finding[J]. Arch Ophthalmol, 2009, 127(12): 1596-1602. doi:10.1001/archophthalmol.2009.326. [18] Goldberg NR, Greenberg JP, Laud K, et al. Outer retinal tubulation in degenerative retinal disorders[J]. Retina, 2013, 33(9): 1871-1876. doi:10.1097/IAE.0b013e318296b12f. [19] Margolis R, Mukkamala SK, Jampol LM, et al. The expanded spectrum of focal choroidal excavation[J]. Arch Ophthalmol, 2011, 129(10): 1320-1325. doi:10.1001/archophthalmol.2011.148. [20] Shukla D, Tanawade RG, Ramasamy K. Transpupillary thermotherapy for subfoveal choroidal neovascular membrane in choroidal osteoma[J]. Eye(Lond), 2006, 20(7): 845-847. doi:10.1038/sj.eye.6702016. [21] Kamalden TA, Lingam G, Sundar G. Bone remodeling in choroidal osteoma monitored by fundus photography and spectral-domain optical coherence tomography[J]. Ocul Oncol Pathol, 2014, 1(1): 13-18. doi:10.1159/000363454. [22] Pierro L, Marchese A, Gagliardi M, et al. Choroidal excavation in choroidal osteoma complicated by choroidal neovascularization[J]. Eye(Lond), 2017, 31(12): 1740-1743. doi:10.1038/eye.2017.136. [23] 梁倩倩, 杨庭骅, 赵博军. 光学相干层析血管扫描在视网膜静脉阻塞中的应用[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 139-142. doi:10.6040/j.issn.1673-3770.0.2018.364. LIANG Qianqian, YANG Tinghua, ZHAO Bojun. Application of optical coherence tomography angiography in retinal vein occlusion[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2):139-142. doi:10.6040/j.issn.1673-3770.0.2018.364. [24] Grisolia ABD, de França Martins M, Demirci H. Imaging of neovascular membrane over a choroidal osteoma by OCT angiography[J]. Ophthalmology, 2018, 125(2): 236. doi:10.1016/j.ophtha.2017.10.025. [25] Rose SJ, Burke JF, Brockhurst RJ. Argon laser photoablation of a choroidal osteoma[J]. Retina, 1991, 11(2): 224-228. doi:10.1097/00006982-199111020-00007. [26] Shields CL, Materin MA, Mehta S, et al. Regression of extrafoveal choroidal osteoma following photodynamic therapy[J]. Arch Ophthalmol, 2008, 126(1): 135-137. doi:10.1001/archopht.126.1.135. [27] Singh AD, Talbot JF, Rundle PA, et al. Choroidal neovascularization secondary to choroidal osteoma: successful treatment with photodynamic therapy[J]. Eye(Lond), 2005, 19(4): 482-484. doi:10.1038/sj.eye.6701475. [28] Foster BS, Fernandez-Suntay JP, Dryja TP, et al. Clinicopathologic reports, case reports, and small case series: surgical removal and histopathologic findings of a subfoveal neovascular membrane associated with choroidal osteoma[J]. Arch Ophthalmol, 2003, 121(2): 273-276. doi:10.1001/archopht.121.2.273. [29] Song JH, Bae JH, Rho MI, et al. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma[J]. Retina, 2010, 30(6): 945-951. doi:10.1097/iae.0b013e3181c720ca. [30] 杨琼, 魏文斌, 刘月明, 等. 玻璃体内注射雷珠单抗治疗继发于脉络膜骨瘤的脉络膜新生血管的初步疗效观察[J]. 眼科, 2019, 28(1): 66-68. doi:10.13281/j.cnki.issn.1004-4469.2019.01.015. [31] Furino C, di Antonio L, Grassi MO, et al. Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: an optical coherence tomography angiography study[J]. Eur J Ophthalmol, 2019, 29(3): 323-329. doi:10.1177/1120672118792187. [32] Yoshikawa T, Takahashi K. Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma[J]. Clin Ophthalmol, 2015, 9: 429-437. doi:10.2147/OPTH.S78817. [33] Najafabadi FF, Hendimarjan SM, Zarrin Y, et al. Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization[J]. J Ophthalmic Vis Res, 2015, 10(4): 484-486. doi:10.4103/2008-322x.176905. |
[1] | 陶冶,周跃华,李福生,王燊,尹鸿芝,祁思,杨海红,单天凤,王芳. FS-LASIK与SMILE术后角膜上皮重塑的比较[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 61-66. |
[2] | 赵娟,周历,司艳芳,毕晓达,张琳. 局限性脉络膜凹陷15例临床观察[J]. 山东大学耳鼻喉眼学报, 2020, 34(1): 85-88. |
[3] | 张韦华,高建鲁. 前房生物学参数测量进展[J]. 山东大学耳鼻喉眼学报, 2012, 26(3): 86-89. |
|